Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hellstern

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1986
[Thrombolytic therapy with ultra-high doses of streptokinase]M Köhler, P Doenecke, P Hellstern, et al.
Vox Sanguinis|August 16, 2006
A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA)T Schulzki, K Seidel, H Storch, et al.
Vox Sanguinis|April 14, 2004
The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markersB Tran-Mi, H Storch, K Seidel, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1986
[Thrombolytic therapy with ultra-high doses of streptokinase]M Köhler, P Doenecke, P Hellstern, et al.
Vox Sanguinis|August 16, 2006
A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA)T Schulzki, K Seidel, H Storch, et al.
Vox Sanguinis|April 14, 2004
The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markersB Tran-Mi, H Storch, K Seidel, et al.
Pageof 9